Patient-Focused Drug Design – A View From The R&D Front Lines




Date:  Friday, April 26, 2019
Time: 11 am EDT 

Register Today

Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. Often, patient factors and insights are not considered or discovered until the later phases of drug development when dose form, dose strength, and route of administration are already decided. There is tremendous potential benefit of equipping formulators and other scientists with patient insights earlier in the development process so that the drug product can be designed to address the specific needs of target patient populations.
 
During this webcast experts will discuss the current state of patient-focused drug design, including key learnings from real world case studies, barriers faced by scientists to incorporate patient-focused drug design principles, and opportunities for drug developers to launch better treatments for patients.

Speakers

Matt Burke, PhD
Head of Drug Delivery
GlaxoSmithKline

Rubi Burlage, PhD
Executive Director, Sterile Formulation Sciences
Merck

Cornell Stamoran, PhD
Vice President, Strategy & Govt. Affairs, Founder & Co-Chair
Catalent Applied Drug Delivery Institute

Register Today